RASCHIONI, CARLOTTA
RASCHIONI, CARLOTTA
Dipartimento di Biotecnologie Mediche e Medicina Traslazionale
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells
2019 A. Gentilini, A. Caligiuri, C. Raggi, K. Rombouts, M. Pinzani, G. Lori, M. Correnti, P. Invernizzi, E. Rovida, N. Navari, S. Di Matteo, D. Alvaro, J.M. Banales, P. Rodrigues, C. Raschioni, M. Donadon, L. Di Tommaso, F. Marra
CXCR4/CXCL12 Signaling and Protumor Macrophages in Primary Tumors and Sentinel Lymph Nodes Are Involved in Luminal B Breast Cancer Progression
2018 C. Raschioni, G. Bottai, A. Sagona, V. Errico, A. Testori, W. Gatzemeier, F. Corsi, C. Tinterri, M. Roncalli, L. Santarpia, L. Di Tommaso
FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression : a Phase II Study
2015 N. Personeni, L. Rimassa, C. Verusio, S. Barni, L. Rubino, S. Bozzarelli, E. Villa, C. Carnaghi, M.C. Tronconi, C. Gerardi, F. Galli, I. Floriani, A. Destro, C. Raschioni, R. Labianca, A. Santoro
TRIP: a pathological score for transarterial chemoembolization resistance individualized prediction in hepatocellular carcinoma
2015 A. Sciarra, M. Ronot, L. Di Tommaso, C. Raschioni, L. Castera, J. Belghiti, P. Bedossa, V. Vilgrain, M. Roncalli, V. Paradis